BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 10.388
AS - Asia 8.391
EU - Europa 4.982
SA - Sud America 1.157
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 25.058
Nazione #
US - Stati Uniti d'America 10.115
SG - Singapore 3.160
VN - Vietnam 1.897
CN - Cina 1.602
RU - Federazione Russa 1.030
HK - Hong Kong 959
BR - Brasile 944
IT - Italia 854
DE - Germania 763
SE - Svezia 657
IE - Irlanda 405
GB - Regno Unito 312
UA - Ucraina 283
CA - Canada 175
FI - Finlandia 153
IN - India 149
KR - Corea 127
FR - Francia 124
AR - Argentina 91
TR - Turchia 90
ID - Indonesia 89
AT - Austria 79
MX - Messico 63
BD - Bangladesh 62
NL - Olanda 60
ZA - Sudafrica 54
ES - Italia 52
PL - Polonia 52
JP - Giappone 48
IQ - Iraq 41
BE - Belgio 36
DK - Danimarca 30
CO - Colombia 25
EC - Ecuador 25
VE - Venezuela 24
LT - Lituania 21
CZ - Repubblica Ceca 20
SA - Arabia Saudita 19
IR - Iran 18
UZ - Uzbekistan 18
EG - Egitto 17
CL - Cile 16
PK - Pakistan 15
CH - Svizzera 11
KE - Kenya 11
MA - Marocco 11
PE - Perù 11
IL - Israele 10
PY - Paraguay 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
MY - Malesia 8
NP - Nepal 7
AZ - Azerbaigian 6
BG - Bulgaria 6
EU - Europa 6
JM - Giamaica 6
JO - Giordania 6
LB - Libano 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GR - Grecia 5
SN - Senegal 5
AU - Australia 4
CR - Costa Rica 4
DZ - Algeria 4
MD - Moldavia 4
PA - Panama 4
PS - Palestinian Territory 4
AO - Angola 3
BH - Bahrain 3
CI - Costa d'Avorio 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
MN - Mongolia 3
NI - Nicaragua 3
OM - Oman 3
PT - Portogallo 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
GD - Grenada 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
Totale 25.036
Città #
Singapore 1.498
Ann Arbor 1.382
Ashburn 1.110
Hong Kong 947
Chandler 643
Woodbridge 635
Hanoi 572
Ho Chi Minh City 527
Fairfield 517
Houston 505
Frankfurt am Main 430
Dublin 396
Santa Clara 334
Dallas 316
New York 305
Jacksonville 300
Wilmington 280
Hefei 271
Los Angeles 251
Seattle 243
Milan 236
Beijing 234
Dearborn 214
Cambridge 199
Princeton 173
Hangzhou 123
Seoul 123
Shanghai 111
The Dalles 106
Buffalo 104
São Paulo 97
Boardman 85
Moscow 85
Nanjing 78
Altamura 74
Chicago 72
Da Nang 70
Munich 70
Jakarta 68
Lawrence 68
Nuremberg 59
Helsinki 54
Dong Ket 51
Lachine 51
Guangzhou 49
San Diego 47
Haiphong 46
Montreal 46
London 43
Tokyo 43
Denver 42
Vienna 42
Warsaw 41
Council Bluffs 37
Hải Dương 37
Quận Bình Thạnh 37
Shenyang 35
Brussels 34
Mountain View 34
Toronto 34
Biên Hòa 32
Quận Một 31
Thái Nguyên 31
Brooklyn 30
Nanchang 30
Orem 30
Poplar 30
Rio de Janeiro 30
Fremont 29
Rome 29
Hebei 27
Andover 26
Johannesburg 26
Stockholm 26
Turku 26
Atlanta 25
Manchester 24
Vũng Tàu 24
Mexico City 23
Boston 22
Ninh Bình 22
Salt Lake City 22
Baghdad 21
Can Tho 21
Phoenix 21
Zhengzhou 21
Ankara 20
Changsha 20
Ha Long 20
Columbus 19
Amsterdam 18
Bắc Giang 18
Carate Brianza 18
Falls Church 18
Jiaxing 18
San Francisco 18
Tashkent 17
Lissone 16
Phủ Lý 16
Seregno 16
Totale 15.645
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.034
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 501
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 461
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 424
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 347
The role of clinical and neuroimaging features in the diagnosis of CADASIL 346
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 335
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 329
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 326
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 322
Guillain-Barré syndrome related to COVID-19 infection 321
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 320
Incidence and predictors of acute symptomatic seizures after stroke 320
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 314
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 303
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 303
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 299
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 299
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 281
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 278
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 273
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 269
Topographical and morphological patterns of post reperfusion molecular penumbra 266
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 264
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 263
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 261
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 258
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 251
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 250
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 250
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 244
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 243
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 243
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 240
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 235
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 235
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 232
Guillain–Barré Syndrome Associated with COVID-19 229
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 228
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 228
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 222
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 222
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 221
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 221
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 220
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 219
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 218
Thermal plantar test in experimental ischemic stroke 218
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 217
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 217
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 216
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 213
A multidisciplinary approach to screen the post-COVID-19 conditions 212
The THRombolysis and STatins (THRaST) study 212
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 209
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 206
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 204
Cerebral collateral circulation in experimental ischemic stroke 203
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 201
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 195
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 190
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 186
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 181
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 175
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 174
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 174
Pharmacological manipulation of glutamate transport 173
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 170
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 170
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 169
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 168
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 168
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 167
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 167
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 164
Brain ultrasound rehearsal before surgery: A pilot cadaver study 162
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 162
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 160
Elevated peripheral leukocyte counts in acute cervical artery dissection 159
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 156
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 156
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 155
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 155
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 152
Possible neuroprotective strategies in ALS 151
Spectral properties of the EEG during recovery of consciousness after acute brain injury 150
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 148
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 144
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 142
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 141
Head down positioning before recanalization in acute ischemic stroke 137
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 136
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 131
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 128
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 128
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 125
Current Developments in Stroke: vol 1 New Concepts in Stroke Diagnosis and Therapy 125
Determinants and outcome of multiple and early recurrent cervical artery dissections 124
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 124
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 122
Totale 22.860
Categoria #
all - tutte 82.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.043 0 0 0 0 0 183 151 139 128 203 80 159
2021/20221.378 129 137 155 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/20267.328 1.750 956 1.047 1.392 1.639 544 0 0 0 0 0 0
Totale 25.705